RBM20 and hypertrophic cardiomyopathy: Supporting this idea is the enrichment of the identified RBM20 targets for tissue-specific diseases associated with RBM20 mutations (DCM, hypertrophic cardiomyopathy and heart failure) according to NCBI Medical Subject Heading (MeSH) (Ho and Lammerding, 2012).